Erosions versus joint space narrowing in rheumatoid arthritis: what do we know?
ANNALS OF THE RHEUMATIC DISEASES (2011)
Journal
ANNALS OF THE RHEUMATIC DISEASES
Volume 70, Issue -, Pages I116-I118Publisher
BMJ PUBLISHING GROUP
Keywords
Categories
Ask authors/readers for more resources
Authors
I am an author on this paper
Reviews
Recommended
Writing an impactful review article: What do we know and what do we need to know?
Justin Paul, Altaf Merchant, Yogesh K. Dwivedi, Gregory Rose
JOURNAL OF BUSINESS RESEARCH (2021)
Cold urticaria - What we know and what we do not know
Natalya Maltseva, Elena Borzova, Daria Fomina, Mojca Bizjak, Dorothea Terhorst-Molawi, Mitja Kosnik, Kanokvalai Kulthanan, Raisa Meshkova, Simon Francis Thomsen, Marcus Maurer
ALLERGY (2021)
Biogenic Silver Nanoparticles: What We Know and What Do We Need to Know?
Mahendra Rai, Avinash P. Ingle, Joanna Trzcinska-Wencel, Magdalena Wypij, Shital Bonde, Alka Yadav, Gabriela Kratosova, Patrycja Golinska
NANOMATERIALS (2021)
What Do We Know about Barley miRNAs?
Adriana Volna, Martin Bartas, Petr Pecinka, Vladimir Spunda, Jiri Cerven
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Amyloidogenesis: What Do We Know So Far?
Zeina Alraawi, Nayan Banerjee, Srujana Mohanty, Thallapuranam Krishnaswamy Suresh Kumar
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Reirradiation for Recurrent Glioblastoma: What We Know and What We Do Not
Jonathan P. S. Knisely, Howard A. Fine
JOURNAL OF CLINICAL ONCOLOGY (2023)
Bacterial Vaginosis: What Do We Currently Know?
Linda Abou Chacra, Florence Fenollar, Khoudia Diop
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2022)
A deep registration method for accurate quantification of joint space narrowing progression in rheumatoid arthritis
Haolin Wang, Yafei Ou, Wanxuan Fang, Prasoon Ambalathankandy, Naoto Goto, Gen Ota, Taichi Okino, Jun Fukae, Kenneth Sutherland, Masayuki Ikebe, Tamotsu Kamishima
COMPUTERIZED MEDICAL IMAGING AND GRAPHICS (2023)
Juvenile Spondyloarthritis: What More Do We Know About HLA-B27, Enthesitis, and New Bone Formation?
Shi Huan Tay, Joo Guan Yeo, Jing Yao Leong, Salvatore Albani, Thaschawee Arkachaisri
FRONTIERS IN MEDICINE (2021)
β Cell and Autophagy: What Do We Know?
Hamid-Reza Mohammadi-Motlagh, Mona Sadeghalvad, Niloofar Yavari, Rosita Primavera, Setareh Soltani, Shashank Chetty, Abantika Ganguly, Shobha Regmi, Tina Floyel, Simranjeet Kaur, Aashiq H. H. Mirza, Avnesh S. S. Thakor, Flemming Pociot, Reza Yarani
BIOMOLECULES (2023)
Oncogenic viruses and chemoresistance: What do we know?
Javid Sadri Nahand, Nikta Rabiei, Reza Fathazam, Mohammad Taghizadieh, Mohammad Saeid Ebrahimi, Maryam Mahjoubin-Tehran, Hossein Bannazadeh Baghi, AliReza Khatami, Mohammad Abbasi-Kolli, Hamid Reza Mirzaei, Neda Rahimian, Maryam Darvish, Hamed Mirzaei
PHARMACOLOGICAL RESEARCH (2021)
Kiwifruit's Allergy in Children: What Do We Know?
Ivana Bringheli, Giulia Brindisi, Rebecca Morelli, Lavinia Marchetti, Ludovica Cela, Alessandro Gravina, Francesca Pastore, Antonio Semeraro, Bianca Cinicola, Martina Capponi, Alessandra Gori, Elia Pignataro, Maria Grazia Piccioni, Anna Maria Zicari, Caterina Anania
NUTRIENTS (2023)
Adjuvants approved for human use: What do we know and what do we need to know for designing good adjuvants?
Cesar Reyes, Manuel A. Patarroyo
EUROPEAN JOURNAL OF PHARMACOLOGY (2023)
Tourist Attribution toward Destination Brands: What Do We Know? What We Do Not Know? Where Should We Be Heading?
Mohamed Arfan Taha Alamrawy, Thowayeb H. Hassan, Mahmoud I. Saleh, Mostafa A. Abdelmoaty, Amany E. Salem, Hassan Marzok Elsayed Mahmoud, Ahmed H. Abdou, Mohamed Y. Helal, Amira Hassan Abdellmonaem, Shaymaa Abdul-Wahab El-Sisi
SUSTAINABILITY (2023)
Revisiting the 'nuclear species' concept: do we really know what we think we know?
Priti Bangal, Hari Sridhar
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2023)
Response to: 'Correspondence on 'Efficacy of a tight-control and treat-to-target strategy in axial spondyloarthritis: results of the open-label, pragmatic, cluster-randomised TICOSPA trial'' by Cai and Peng response
Anna Molto, Desiree van der Heijde, Filip E. van den Bosch, Maxime Dougados
ANNALS OF THE RHEUMATIC DISEASES (2023)
Correspondence on 'Re-examining remission definitions in rheumatoid arthritis: considering the 28-joint Disease Activity Score, C reactive protein level and patient global assessment' by Felson et al
Ricardo J. O. Ferreira, Paco M. J. Welsing, Johannes W. G. Jacobs, Laure Gossec, Mwidimi Ndosi, Pedro M. Machado, Desiree van der Heijde, Jose A. P. Da Silva
ANNALS OF THE RHEUMATIC DISEASES (2023)
Efficacy and safety of biological DMARDs: a systematic literature review informing the 2022 update of the ASAS-EULAR recommendations for the management of axial spondyloarthritis
Casper Webers, Augusta Ortolan, Alexandre Sepriano, Louise Falzon, Xenofon Baraliakos, Robert B. M. Landewe, Sofia Ramiro, Desiree van der Heijde, Elena Nikiphorou
ANNALS OF THE RHEUMATIC DISEASES (2023)
The effect of anti-inflammatory treatment on depressive symptoms in spondyloarthritis: does the type of drug matter?
Casper Webers, Uta Kiltz, Juergen Braun, Desiree van der Heijde, Annelies Boonen
RHEUMATOLOGY (2023)
Efficacy and safety of bimekizumab in axial spondyloarthritis: results of two parallel phase 3 randomised controlled trials
Desiree van der Heijde, Atul Deodhar, Xenofon Baraliakos, Matthew A. Brown, Hiroaki Dobashi, Maxime Dougados, Dirk Elewaut, Alicia M. Ellis, Carmen Fleurinck, Karl Gaffney, Lianne S. Gensler, Nigil Haroon, Marina Magrey, Walter P. Maksymowych, Alexander Marten, Ute Massow, Marga Oortgiesen, Denis Poddubnyy, Martin Rudwaleit, Julie Shepherd-Smith, Tetsuya Tomita, Filip van den Bosch, Thomas Vaux, Huji Xu
ANNALS OF THE RHEUMATIC DISEASES (2023)
Efficacy of synthetic and biological DMARDs: a systematic literature review informing the 2022 update of the EULAR recommendations for the management of rheumatoid arthritis
Andreas Kerschbaumer, Alexandre Sepriano, Sytske Anne Bergstra, Josef S. Smolen, Desiree van der Heijde, Roberto Caporali, Christopher John Edwards, Patrick Verschueren, Savia de Souza, Janet E. Pope, Tsutomu Takeuchi, Kimme L. Hyrich, Kevin L. Winthrop, Daniel Aletaha, Tanja A. Stamm, Jan W. Schoones, Robert B. M. Landewe
ANNALS OF THE RHEUMATIC DISEASES (2023)
Safety of synthetic and biological DMARDs: a systematic literature review informing the 2022 update of the EULAR recommendations for the management of rheumatoid arthritis
Alexandre Sepriano, Andreas Kerschbaumer, Sytske Anne Bergstra, Josef S. Smolen, Desiree van der Heijde, Roberto Caporali, Christopher J. Edwards, Patrick Verschueren, Savia de Souza, Janet Pope, Tsutomu Takeuchi, Kimme Hyrich, Kevin L. Winthrop, Daniel Aletaha, Tanja Stamm, Jan W. Schoones, Robert B. M. Landewe
ANNALS OF THE RHEUMATIC DISEASES (2023)
Efficacy, duration of use and safety of glucocorticoids: a systematic literature review informing the 2022 update of the EULAR recommendations for the management of rheumatoid arthritis
Sytske Anne Bergstra, Alexandre Sepriano, Andreas Kerschbaumer, Desiree van der Heijde, Roberto Caporali, Christopher John Edwards, Patrick Verschueren, Savia de Souza, Janet E. Pope, Tsutomu Takeuchi, Kimme L. Hyrich, Kevin L. Winthrop, Daniel Aletaha, Tanja A. Stamm, Jan W. Schoones, Josef S. Smolen, Robert B. M. Landewe
ANNALS OF THE RHEUMATIC DISEASES (2023)
Stricter treat-to-target in RA does not result in less radiographic progression: a longitudinal analysis in RA BIODAM
Sofia Ramiro, Robert Landewe, Desiree van der Heijde, Alexandre Sepriano, Oliver FitzGerald, Mikkel Ostergaard, Joanne Homik, Ori Elkayam, J. Carter Thorne, Maggie J. Larche, Gianfranco Ferraccioli, Marina Backhaus, Gilles Boire, Bernard Combe, Thierry Schaeverbeke, Alain Saraux, Maxime Dougados, Maurizio Rossini, Marcello Govoni, Luigi Sinigaglia, Alain G. Cantagrel, Cornelia F. Allaart, Cheryl Barnabe, Clifton O. Bingham III, Dirkjan van Schaardenburg, Hilde B. Hammer, Rana Dadashova, Edna Hutchings, Joel Paschke, Walter P. Maksymowych
RHEUMATOLOGY (2023)
Response to: Correspondence on ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update by Ramiro et al
Sofia Ramiro, Elena Nikiphorou, Alexandre Sepriano, Augusta Ortolan, Casper Webers, Xenofon Baraliakos, Robert B. M. Landewe, Desiree van der Heijde
ANNALS OF THE RHEUMATIC DISEASES (2023)
ASAS consensus definition of early axial spondyloarthritis
Victoria Navarro-Compan, Diego Benavent, Dafne Capelusnik, Desiree van der Heijde, Robert B. M. Landewe, Denis Poddubnyy, Astrid van Tubergen, Xenofon Baraliakos, Filip E. van den Bosch, Floris A. van Gaalen, Lianne Gensler, Clementina Lopez-Medina, Helena Marzo-Ortega, Anna Molto, Rodolfo Perez-Alamino, Martin Rudwaleit, Marleen van de Sande, Raj Sengupta, Ulrich Weber, Sofia Ramiro
ANNALS OF THE RHEUMATIC DISEASES (2023)
Long-Term Safety and Efficacy of Ixekizumab in Patients With Axial Spondyloarthritis: 3-year Data From the COAST Program (Feb, 10.3899/jrheum.221022, 2023)
Atul Deodhar, Denis Poddubnyy, Proton Rahman, Jeorg Ermann, Tetsuya Tomita, Rebeca Bolce, Soyi Liu Leage, Andris Kronbergs, Caroline Johnson, Joana Araujo, Ann Leung, Desiree van der Heijde
JOURNAL OF RHEUMATOLOGY (2023)
Good construct validity of the CT Syndesmophyte Score (CTSS) in patients with radiographic axial spondyloarthritis
Rosalinde Stal, Sofia Ramiro, Xenofon Baraliakos, Juergen Braun, Monique Reijnierse, Rosaline van den Berg, Desiree van der Heijde, Floris A. van Gaalen
RMD OPEN (2023)
Inflammation, bone loss and 2-year bone formation at the same vertebra in axial spondyloarthritis: a multilevel MRI and low-dose CT analysis
Mary Lucy Marques, Nuno Pereira da Silva, Desiree van der Heijde, Rosalinde Stal, Xenofon Baraliakos, Juergen Braun, Monique Reijnierse, Caroline Bastiaenen, Sofia Ramiro, Floris A. van Gaalen
RMD OPEN (2023)
Subclinical inflammation and joint damage progression in patients with early RA fulfilling 2011 vs 2022 ACR/EULAR Boolean remission criteria: data from the ARCTIC study
Valeriia Melokhina, Nina Paulshus Sundlisaeter, Joseph Sexton, Ulf Sundin, Anna-Birgitte Aga, Kaja E. Kjorholt, Lena Bugge Nordberg, Desiree van der Heijde, Espen Haavardsholm, Siri Lillegraven
ANNALS OF THE RHEUMATIC DISEASES (2023)